![Mathias Hukkelhoven](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathias Hukkelhoven
Directeur/Membre du Conseil chez
COMPUGEN LTD.
Fortune : 21 400 $ au 30/06/2026
Profil
Mathias Hukkelhoven is currently an Independent Director at Compugen Ltd. since 2022 and a Partner at Panacea Venture Management Co., Ltd. Former positions include Chairman-Portfolio Stewardship at Novartis Pharmaceuticals Corp., Independent Non-Executive Director at Centessa Pharmaceuticals Plc from 2022 to 2026, Senior VP-Global Head Drug Regulatory Affairs at Novartis Pharmaceuticals Corp.
from 2001 to 2009, and SVP-Global Regulatory, Safety & Biometrics at Bristol-Myers Squibb (Israel) Ltd. from 2010 to 2021.
Education includes undergraduate and doctorate degrees from Radboud University Nijmegen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COMPUGEN LTD. 0,01% | 18/03/2026 | 10 000 ( 0,01% ) | 21 400 $ | 30/06/2026 |
Postes actifs de Mathias Hukkelhoven
| Sociétés | Poste | Début |
|---|---|---|
| COMPUGEN LTD. | Directeur/Membre du Conseil | 01/03/2022 |
Panacea Venture Management Co., Ltd.
 Panacea Venture Management Co., Ltd. Investment ManagersFinance Operates as a venture capital firm | Corporate Officer/Principal | - |
Anciens postes connus de Mathias Hukkelhoven
| Sociétés | Poste | Fin |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 24/06/2026 |
Bristol-Myers Squibb (Israel) Ltd. | Conseiller Juridique Général | 01/07/2021 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Conseiller Juridique Général | 01/01/2009 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | - |
Formation de Mathias Hukkelhoven
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Compugen Ltd.
 Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Radboud University Nijmegen
 Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb (Israel) Ltd. | |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
Panacea Venture Management Co., Ltd.
Panacea Venture Management Co., Ltd. Investment ManagersFinance Operates as a venture capital firm | Finance |
